Medicare Enrolled
David French
Neurology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about French from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you French?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about French
David French is a neurology specialist in Houston, TX, with 9 years of NPI registration. Based on federal Medicare data, French performed 1,427 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, French received a total of $6,695 from 55 pharmaceutical and/or device companies across 343 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for French is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years of NPI registration
▲ Top 23% volume in TX
$6,695 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,427
Medicare services
Top 23% in TX for neurology
Not available
Unique patients (not deduplicated)
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
438 | $96 | $501 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
314 | $124 | $1,000 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
196 | $74 | $400 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
87 | $219 | $1,600 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
76 | $112 | $2,700 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
66 | $84 | $800 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $69 | $400 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
47 | $282 | $1,400 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
45 | $185 | $1,400 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
20 | $47 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $304 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
17 | $128 | $500 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
13 | $169 | $3,500 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
12 | $162 | $600 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
12 | $168 | $500 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
12 | $125 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,695
Total received (2022-2024)
Avg $2,232/year across 3 years
Top 34% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
343
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,412
2023
$3,439
2022
$843
Payments by company (2024)
ABBVIE INC.
$617
Teva Pharmaceuticals USA, Inc.
$227
Lundbeck LLC
$189
Novartis Pharmaceuticals Corporation
$167
Genentech USA, Inc.
$161
Kyowa Kirin, Inc.
$94
ACADIA Pharmaceuticals Inc
$79
PFIZER INC.
$78
Celgene Corporation
$66
Biogen, Inc.
$65
UCB, Inc.
$61
TG Therapeutics, Inc.
$60
SK Life Science, Inc.
$54
Amgen Inc.
$49
SCILEX PHARMACEUTICALS INC.
$48
JAZZ PHARMACEUTICALS INC.
$40
ARGENX US, INC.
$34
Grifols USA, LLC
$30
MITSUBISHI TANABE PHARMA AMERICA, INC.
$28
Neurocrine Biosciences, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
Alexion Pharmaceuticals, Inc.
$24
Averitas Pharma Inc.
$24
Kedrion Biopharma, Inc.
$24
Amneal Pharmaceuticals LLC
$20
Abbott Laboratories
$19
GE HEALTHCARE
$18
Eisai Inc.
$18
Lilly USA, LLC
$18
Azurity Pharmaceuticals, Inc.
$18
Neurelis, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2022-2024) ›
ABBVIE INC.
$1,247
Teva Pharmaceuticals USA, Inc.
$550
PFIZER INC.
$323
Novartis Pharmaceuticals Corporation
$306
Celgene Corporation
$301
UCB, Inc.
$296
Genentech USA, Inc.
$282
Biogen, Inc.
$281
Lundbeck LLC
$242
ACADIA Pharmaceuticals Inc
$229
SK Life Science, Inc.
$219
ARGENX US, INC.
$165
Neurocrine Biosciences, Inc.
$142
Sumitomo Pharma America, Inc.
$139
Amgen Inc.
$113
Alexion Pharmaceuticals, Inc.
$105
Biohaven Pharmaceutical Holding Company Ltd.
$101
Grifols USA, LLC
$101
Takeda Pharmaceuticals U.S.A., Inc.
$99
E.R. Squibb & Sons, L.L.C.
$98
Kyowa Kirin, Inc.
$94
Lilly USA, LLC
$85
MITSUBISHI TANABE PHARMA AMERICA, INC.
$84
Corium, LLC
$81
Merz Pharmaceuticals, LLC
$63
TG Therapeutics, Inc.
$60
Aprecia Pharmaceuticals, LLC
$58
Abbott Laboratories
$53
Otsuka America Pharmaceutical, Inc.
$53
JAZZ PHARMACEUTICALS INC.
$52
SCILEX PHARMACEUTICALS INC.
$48
CSL Behring
$45
Neurelis, Inc.
$43
Acorda Therapeutics, Inc
$40
Eisai Inc.
$35
Janssen Pharmaceuticals, Inc
$34
Jazz Pharmaceuticals Inc.
$33
Azurity Pharmaceuticals, Inc.
$32
Sandoz Inc.
$32
UPSHER-SMITH LABORATORIES LLC
$28
TG THERAPEUTICS, INC.
$24
Averitas Pharma Inc.
$24
Kedrion Biopharma, Inc.
$24
Octapharma USA, Inc.
$24
BANNER LIFE SCIENCES, LLC
$23
GENZYME CORPORATION
$23
Medtronic, Inc.
$22
Amneal Pharmaceuticals LLC
$20
Allergan, Inc.
$20
Alnylam Pharmaceuticals Inc.
$20
GE HEALTHCARE
$18
MDD US Operations, LLC
$18
Sunovion Pharmaceuticals Inc.
$17
Harmony Biosciences LLC
$16
Avanir Pharmaceuticals, Inc.
$12
Top 3 companies account for 31.7% of all-time payments
Associated products mentioned in payments ›
AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · DAYBUE · EMGALITY · EPIDIOLEX · Enspryng · GAMMAGARD · GILENYA · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · Leqembi · MAYZENT · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · PAXLOVID · PROCLAIM · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Skyclarys · Spritam · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Wakix · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
382
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
French is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is French experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, French performed 438 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does French receive payments from pharmaceutical companies?
Yes. French received a total of $6,695 from 55 companies across 343 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do French's costs compare to other neurologists in Houston?
French's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for French) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Houston
Browse neurologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology